IL141359A0 - Method of manufacture of 1,3-oxathiolane nucleosides - Google Patents

Method of manufacture of 1,3-oxathiolane nucleosides

Info

Publication number
IL141359A0
IL141359A0 IL14135999A IL14135999A IL141359A0 IL 141359 A0 IL141359 A0 IL 141359A0 IL 14135999 A IL14135999 A IL 14135999A IL 14135999 A IL14135999 A IL 14135999A IL 141359 A0 IL141359 A0 IL 141359A0
Authority
IL
Israel
Prior art keywords
oxathiolane
manufacture
oxathiolane nucleosides
preparation
nucleosides
Prior art date
Application number
IL14135999A
Other languages
English (en)
Original Assignee
Triangle Pharmaceuticals Inc
Univ Emory
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Triangle Pharmaceuticals Inc, Univ Emory filed Critical Triangle Pharmaceuticals Inc
Publication of IL141359A0 publication Critical patent/IL141359A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D327/00—Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms
    • C07D327/02—Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms one oxygen atom and one sulfur atom
    • C07D327/04—Five-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D411/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms
    • C07D411/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D411/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
IL14135999A 1998-08-12 1999-08-12 Method of manufacture of 1,3-oxathiolane nucleosides IL141359A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US9621498P 1998-08-12 1998-08-12
US12284199P 1999-03-04 1999-03-04
PCT/US1999/018584 WO2000009494A1 (en) 1998-08-12 1999-08-12 Method of manufacture of 1,3-oxathiolane nucleosides

Publications (1)

Publication Number Publication Date
IL141359A0 true IL141359A0 (en) 2002-03-10

Family

ID=26791450

Family Applications (4)

Application Number Title Priority Date Filing Date
IL14135999A IL141359A0 (en) 1998-08-12 1999-08-12 Method of manufacture of 1,3-oxathiolane nucleosides
IL141359A IL141359A (en) 1998-08-12 2001-02-09 Method for the formation of 3,1-oxathiolane nucleosides
IL173745A IL173745A (en) 1998-08-12 2006-02-15 Method of manufacture of 1,3-oxathiolane nucleoside analogs
IL201293A IL201293A (en) 1998-08-12 2009-10-01 Method for the formation of analogues 1, 3 - oxathiolane nucleosides

Family Applications After (3)

Application Number Title Priority Date Filing Date
IL141359A IL141359A (en) 1998-08-12 2001-02-09 Method for the formation of 3,1-oxathiolane nucleosides
IL173745A IL173745A (en) 1998-08-12 2006-02-15 Method of manufacture of 1,3-oxathiolane nucleoside analogs
IL201293A IL201293A (en) 1998-08-12 2009-10-01 Method for the formation of analogues 1, 3 - oxathiolane nucleosides

Country Status (17)

Country Link
US (4) US6215004B1 (es)
EP (4) EP2322518B1 (es)
JP (4) JP4249393B2 (es)
KR (3) KR101208429B1 (es)
CN (1) CN1141305C (es)
AT (2) ATE292631T1 (es)
AU (2) AU771779B2 (es)
BR (1) BR9912951B1 (es)
CA (3) CA2340214C (es)
DE (2) DE69921829T2 (es)
ES (2) ES2232169T3 (es)
HK (2) HK1038921A1 (es)
IL (4) IL141359A0 (es)
MX (1) MXPA01001552A (es)
PT (2) PT1104415E (es)
RU (2) RU2244712C2 (es)
WO (1) WO2000009494A1 (es)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5684164A (en) * 1988-04-11 1997-11-04 Biochem Pharma Inc. Processes for preparing substituted 1,3-oxathiolanes with antiviral properties
KR101208429B1 (ko) * 1998-08-12 2012-12-05 길리애드 사이언시즈, 인코포레이티드 1,3-옥사티올란 뉴클레오시드의 제조 방법
CA2308559C (en) 2000-05-16 2005-07-26 Brantford Chemicals Inc. 1,3-oxathiolan-5-ones useful in the production of antiviral nucleoside analogues
KR20040002871A (ko) 2001-03-01 2004-01-07 트라이앵글 파마슈티칼스 인코포레이티드 시스-ｆｔｃ의 다형 및 기타 결정형
AU2008202336B2 (en) * 2001-03-01 2011-11-10 Abbvie Inc. Polymorphic and other crystalline forms of cis-FTC
EA006372B1 (ru) * 2001-06-15 2005-12-29 Шаэр Биокем, Инк. Стереоселективный способ получения нуклеозидных аналогов
CA2351049C (en) 2001-06-18 2007-03-13 Brantford Chemicals Inc. Process for recovery of the desired cis-1,3-oxathiolane nucleosides from their undesired trans-isomers
WO2003051298A2 (en) * 2001-12-14 2003-06-26 Pharmasset Ltd. Preparation of intermediates useful in the synthesis of antiviral nucleosides
DK1556371T3 (da) * 2002-07-19 2006-08-21 Winston Pharmaceuticals Llc Benzimidazol-derivater og deres anvendelse som prodrugs for protonpumpe-inhibitorer
DE60335805D1 (de) 2002-08-06 2011-03-03 Pharmasset Inc Verfahren zur herstellung von 1,3-dioxolan-nucleosiden
DK1583542T3 (da) * 2003-01-14 2008-09-22 Gilead Sciences Inc Sammensætninger og fremgangsmåder til antiviral kombinationsterapi
JPWO2005056870A1 (ja) * 2003-12-09 2007-12-13 旭硝子株式会社 可視光で光触媒活性を有するＴｉ酸化物膜およびその製造方法
CA2554782C (en) 2004-02-03 2013-08-13 Emory University Methods to manufacture 1,3-dioxolane nucleosides
CA2667891A1 (en) * 2006-10-30 2008-05-08 Lupin Limited An improved process for the manufacture of lamivudine
MX2010003521A (es) * 2007-09-28 2010-04-27 Avexa Ltd Un proceso para la resolucion quiral de 1,3-oxatiolanos 2 sustituidos 4-sustituidos.
EP2050757A1 (en) * 2007-10-10 2009-04-22 Cilag AG Method of producing 2' -deoxy-5-azacytidine (Decitabine)
EP2048151A1 (en) * 2007-10-10 2009-04-15 Cilag AG Method for producing nucleosides by direct glycosylation of the nucleoside base
US20110288298A1 (en) * 2008-11-12 2011-11-24 Lupin Limited novel polymorph of emtricitabine and a process for preparing of the same
US20110282046A1 (en) 2009-01-19 2011-11-17 Rama Shankar Process for preparation of cis-nucleoside derivative
US8710218B2 (en) 2009-07-15 2014-04-29 Lupin Limited Process for preparation of Efavirenz
WO2011141805A2 (en) 2010-05-14 2011-11-17 Lupin Limited An improved process for the manufacture of lamivudine
US20130296562A1 (en) 2011-08-05 2013-11-07 Lupin Limited Stereoselective process for preparation of 1,3-oxathiolane nucleosides
CN106478618A (zh) * 2016-10-14 2017-03-08 上海礼泰医药科技有限公司 恩曲他滨氢卤酸盐的制备方法
CN109553610B (zh) * 2018-12-21 2020-10-27 江西富祥药业股份有限公司 一种恩曲他滨异构体的制备方法
CN115043823A (zh) * 2022-06-28 2022-09-13 江苏普信制药有限公司 一种恩曲他滨的合成方法

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ228645A (en) 1988-04-11 1991-09-25 Iaf Biochem Int 1,3-dioxolane derivatives substituted in the 5th position by a purine or pyrimidine radical; treatment of viral infections
US5466806A (en) 1989-02-08 1995-11-14 Biochem Pharma Inc. Processes for preparing substituted 1,3-oxathiolanes with antiviral properties
US5684164A (en) 1988-04-11 1997-11-04 Biochem Pharma Inc. Processes for preparing substituted 1,3-oxathiolanes with antiviral properties
US5041449A (en) 1988-04-11 1991-08-20 Iaf Biochem International, Inc. 4-(nucleoside base)-substituted-1,3-dioxolanes useful for treatment of retroviral infections
US5047407A (en) 1989-02-08 1991-09-10 Iaf Biochem International, Inc. 2-substituted-5-substituted-1,3-oxathiolanes with antiviral properties
US5700937A (en) 1990-02-01 1997-12-23 Emory University Method for the synthesis, compositions and use of 2'-deoxy-5-fluoro-3'-thiacytidine and related compounds
US5204466A (en) 1990-02-01 1993-04-20 Emory University Method and compositions for the synthesis of bch-189 and related compounds
US5728575A (en) 1990-02-01 1998-03-17 Emory University Method of resolution of 1,3-oxathiolane nucleoside enantiomers
US6642245B1 (en) 1990-02-01 2003-11-04 Emory University Antiviral activity and resolution of 2-hydroxymethyl-5-(5-fluorocytosin-1-yl)-1,3-oxathiolane
US5276151A (en) 1990-02-01 1994-01-04 Emory University Method of synthesis of 1,3-dioxolane nucleosides
GB9009861D0 (en) 1990-05-02 1990-06-27 Glaxo Group Ltd Chemical compounds
US5587480A (en) 1990-11-13 1996-12-24 Biochem Pharma, Inc. Substituted 1,3-oxathiolanes and substituted 1,3-dithiolanes with antiviral properties
US5444063A (en) 1990-12-05 1995-08-22 Emory University Enantiomerically pure β-D-dioxolane nucleosides with selective anti-Hepatitis B virus activity
US5248776A (en) 1990-12-05 1993-09-28 University Of Georgia Research Foundation, Inc. Process for enantiomerically pure β-L-1,3-oxathiolane nucleosides
AU9125991A (en) * 1990-12-05 1992-07-08 University Of Georgia Research Foundation, Inc., The Enantiomerically pure beta -l-(-)-1,3-oxathiolane nucleosides
NZ241625A (en) 1991-02-22 1996-03-26 Univ Emory 1,3-oxathiolane derivatives, anti-viral compositions containing such and method of resolving racemic mixture of enantiomers
GB9104740D0 (en) 1991-03-06 1991-04-17 Wellcome Found Antiviral nucleoside combination
DK0574487T3 (da) 1991-03-06 2002-10-14 Univ Emory Anvendelse af 5-fluor-2'-deoxy-thiacytidin til behandling af hepatitis B
IT1244501B (it) 1991-03-22 1994-07-15 Sigma Tau Ind Farmaceuti Derivati amminoacilici e oligopeptidici dell'allopurinolo dotati di attivita' immunostimolante e composizioni farmaceutiche che li contengono
WO1992018517A1 (en) 1991-04-17 1992-10-29 Yale University Method of treating or preventing hepatitis b virus
GB9110874D0 (en) 1991-05-20 1991-07-10 Iaf Biochem Int Medicaments
ZA923641B (en) 1991-05-21 1993-02-24 Iaf Biochem Int Processes for the diastereoselective synthesis of nucleosides
GB9116601D0 (en) 1991-08-01 1991-09-18 Iaf Biochem Int 1,3-oxathiolane nucleoside analogues
GB9311709D0 (en) 1993-06-07 1993-07-21 Iaf Biochem Int Stereoselective synthesis of nucleoside analogues using bicycle intermediate
IL113432A (en) * 1994-04-23 2000-11-21 Glaxo Group Ltd Process for the diastereoselective synthesis of nucleoside analogues
KR100226533B1 (ko) 1994-07-08 1999-10-15 나까니시 히로유끼 열가소성 폴리에스테르수지 조성물
GB9506644D0 (en) 1995-03-31 1995-05-24 Wellcome Found Preparation of nucleoside analogues
GB9525606D0 (en) 1995-12-14 1996-02-14 Iaf Biochem Int Method and compositions for the synthesis of dioxolane nucleosides with › - configuration
TW318283B (en) 1996-12-09 1997-10-21 United Microelectronics Corp Multi-level read only memory structure and manufacturing method thereof
KR101208429B1 (ko) * 1998-08-12 2012-12-05 길리애드 사이언시즈, 인코포레이티드 1,3-옥사티올란 뉴클레오시드의 제조 방법
US9308044B2 (en) 2002-04-08 2016-04-12 Medtronic Ardian Luxembourg S.A.R.L. Methods for therapeutic renal neuromodulation
US9109124B2 (en) 2011-06-01 2015-08-18 Xerox Corporation Solid ink compositions comprising semicrystalline oligomer resins
JP5800924B2 (ja) 2014-01-20 2015-10-28 ファナック株式会社 回転工具の回転振れ及び動バランス調整機構

Also Published As

Publication number Publication date
BR9912951B1 (pt) 2012-01-10
AU2004202930C1 (en) 2008-11-13
US6576776B1 (en) 2003-06-10
HK1156604A1 (en) 2012-06-15
EP2322518A1 (en) 2011-05-18
CA2340214C (en) 2007-10-30
KR100856416B1 (ko) 2008-09-04
PT2322518E (pt) 2015-06-08
CA2563022C (en) 2010-11-23
KR20070094667A (ko) 2007-09-20
PT1104415E (pt) 2005-03-31
CA2340214A1 (en) 2000-02-24
JP2002522534A (ja) 2002-07-23
CA2563022A1 (en) 2000-02-24
CA2714085C (en) 2013-02-05
ES2537540T3 (es) 2015-06-09
KR20060063991A (ko) 2006-06-12
RU2004125183A (ru) 2006-01-27
IL141359A (en) 2006-07-05
AU5675299A (en) 2000-03-06
JP2009108080A (ja) 2009-05-21
IL173745A0 (en) 2006-07-05
US6939965B2 (en) 2005-09-06
KR101208429B1 (ko) 2012-12-05
US6518425B1 (en) 2003-02-11
ATE292631T1 (de) 2005-04-15
IL201293A (en) 2011-02-28
AU2004202930B2 (en) 2008-05-08
AU2004202930A1 (en) 2004-07-29
EP1535921A1 (en) 2005-06-01
EP1361223A1 (en) 2003-11-12
JP4249393B2 (ja) 2009-04-02
DE69921829D1 (de) 2004-12-16
JP5203897B2 (ja) 2013-06-05
WO2000009494A1 (en) 2000-02-24
KR20010072428A (ko) 2001-07-31
IL173745A (en) 2010-05-31
MXPA01001552A (es) 2004-08-23
CN1141305C (zh) 2004-03-10
EP1361223B1 (en) 2005-04-06
RU2244712C2 (ru) 2005-01-20
ATE282034T1 (de) 2004-11-15
KR100687194B1 (ko) 2007-02-27
RU2439069C2 (ru) 2012-01-10
JP2014132026A (ja) 2014-07-17
EP1104415A1 (en) 2001-06-06
EP2322518B1 (en) 2015-02-25
CN1313858A (zh) 2001-09-19
HK1038921A1 (en) 2002-04-04
US20030144532A1 (en) 2003-07-31
BR9912951A (pt) 2001-10-02
DE69924651D1 (de) 2005-05-12
EP1104415B1 (en) 2004-11-10
JP5956492B2 (ja) 2016-07-27
DE69921829T2 (de) 2005-10-27
US6215004B1 (en) 2001-04-10
CA2714085A1 (en) 2000-02-24
JP5547772B2 (ja) 2014-07-16
ES2232169T3 (es) 2005-05-16
AU771779B2 (en) 2004-04-01
JP2012176974A (ja) 2012-09-13
IL201293A0 (en) 2010-05-31

Similar Documents

Publication Publication Date Title
IL173745A0 (en) Method of manufacture of 1,3-oxathiolane nucleosides
IL210398A0 (en) Novel triazolo (4, 5 - d) pyrimidine
SI1155015T1 (sl) Postopek za proizvodnjo terc.-butil (E)-(6-(2-(4-(4-fluorofenil)-6- izopropil-2-(metil(metilsulfonil)amino)pirimidin-5-il)vinil)(4R,6S)-2, 2-dimetil-(1,3)dioksan-4-il)acetata
ATE334136T1 (de) Verfahren zur herstellung von azithromycin
HUP0303590A3 (en) Method for the production of 4,6-diaminopyrimido[5,4-d]pyrimidines
DE68923171D1 (de) Aluminiumhydroxyd, verfahren zur herstellung und zusammensetzung.
ATE483691T1 (de) Verfahren zur herstellung von unsymmetrischen 4,6-bis(aryloxy)pyrimidin-derivaten
IL126989A (en) Process for making 4,6-dihydroxypyrimidine
IL138288A0 (en) Process for the production of purine derivatives and intermediates thereof
ZA99477B (en) Process for the preparation of (-)CIS-3-Hydroxy-1-Methyl-4-(2,4,6-Trimethoxyphenyl)Piperidine.
DK368587D0 (da) Fremgangsmaade til fremstilling af 5,6-substitueret-2,4-quinazolindiaminer samt mellemproduktforbindelser
AU6726598A (en) Method for generating embryogenic cell cultures for the production of transgenicbananas (musa spp.)
ZA971948B (en) Process for the preparation of unsymmetrical 4,6-bis (aryloxy)pyrimidine compounds
EP0968997A3 (en) Process for S-aryl-L-cysteine and derivatives
ATE209636T1 (de) Verbessertes verfahren zur herstellung von unsymmetrischen 4,6- bis(aryloxy)pyrimidinverbindungen
BR9607850A (pt) Processo para a preparação de um composto e composto
PL335215A1 (en) Method of obtaining polyetheroles with the 1,3,5-triazine ring
ZA200002057B (en) Process for preparing 8-cyclopentyl-6-ethyl-3-(substituted)-5,8-dihydro-4H-1,2,3A,7,8-pentaaza-as-indacenes and intermediates useful therein.
AU2002308194A1 (en) Method for the production of 4,6-diaminopyrimido(5,4-d)pyrimidines
NO910445D0 (no) Fremgangsmaate for fremstilling av 6-(10-hydroksydecyl)-2,3-dimetoksy-5-metyl-1,4-benzoquinon samt analoge forbindelser.
HU9901025D0 (en) N-oxiranemethyl-piperidin enantiomers and process for producing them by resolving the racemic compond
PL297783A1 (en) Method of obtaining 4-sulfanilamido-2,6-dimethoxypyrimidine

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed